{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ovarian cancer", "bioactive molecules", "biomarkers", "delivery vehicles", "exosomes", "extracellular vesicles."]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38284712", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "06"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0115680096281906231213055422"], "ArticleDate": [], "Journal": {"ISSN": "1873-5576", "JournalIssue": {"Volume": "24", "Issue": "9", "PubDate": {"Year": "2024"}}, "Title": "Current cancer drug targets", "ISOAbbreviation": "Curr Cancer Drug Targets"}, "ArticleTitle": "Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.", "Pagination": {"StartPage": "920", "EndPage": "929", "MedlinePgn": "920-929"}, "Abstract": {"AbstractText": ["Exosomes are very small (nano-sized) vesicles participating in tumor development by involvement in intercellular communication mediated by transferring biocomponents. Exosomes appear to play vital roles in various cancer development, such as ovarian cancer, a common malignancy in women. Several hallmarks of ovarian cancer are reported to be affected by the exosomemediated cellular cross-talk, including modulating peritoneal dissemination and chemoresistance. Since the expression of some biomolecules, such as miRNAs and mRNA, is changed in ovarian cancer, these exo-biomolecules can be applied as prognostic, diagnostic, and therapeutic biomarkers. Also, the selective loading of specific chemotherapeutic agents into exosomes highlights these biocarries as potential delivery devices. Exosomes could be artificially provided and engineered to better target the site of interest in ovarian cancer. In the present review, we summarize the notable achievement of exosome application in ovarian cancer management to gain applicable transitional insight against this cancer."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Keyvani", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Ghale-Noie", "ForeName": "Zari Naderi", "Initials": "ZN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Mahmoudian", "ForeName": "Reihaneh Alsadat", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq."}], "LastName": "Ghorbani", "ForeName": "Elnaz", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Naderi", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Khazaei", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hassanian", "ForeName": "Seyed Mahdi", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, BN1 9PH, UK."}], "LastName": "Ferns", "ForeName": "Gordon A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Faculty of Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, 4059, Australia."}, {"Identifier": [], "Affiliation": "College of Medicine and Health Sciences, National University of Science and Technology, Sultanate of Oman."}], "LastName": "Avan", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Anvari", "ForeName": "Kazem", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Curr Cancer Drug Targets", "NlmUniqueID": "101094211", "ISSNLinking": "1568-0096"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Exosomes"}, {"QualifierName": ["drug therapy", "pathology", "metabolism", "therapy"], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Feng W.; Dean D.C.; Hornicek F.J.; Shi H.; Duan Z.; Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer 2019,18(1),124", "ArticleIdList": ["10.1186/s12943-019-1049-4", "31409361"]}, {"Citation": "Cabasag C.J.; Fagan P.J.; Ferlay J.; Vignat J.; Laversanne M.; Liu L.; van der Aa M.A.; Bray F.; Soerjomataram I.; Ovarian cancer today and tomorrow: A global assessment by world region and human development index using 2020. Int J Cancer 2022,151(9),1535-1541", "ArticleIdList": ["10.1002/ijc.34002", "35322413"]}, {"Citation": "Xu Z.; Zeng S.; Gong Z.; Yan Y.; Inmunoterapia basada en exosomas: un enfoque prometedor para el tratamiento del c\u00e1ncer. Mol Cancer 2020,19(1)"}, {"Citation": "Soleimani M.; Homayoun M.; Sajedi N.; In vitro evaluation of the pogostone effects on the expression of PTEN and DACT1 tumor suppressor genes, cell cycle, and apoptosis in ovarian cancer cell line. Res Pharm Sci 2022,17(2),164-175", "ArticleIdList": ["10.4103/1735-5362.335175", "35280836"]}, {"Citation": "Lo Presti E.; Pizzolato G.; Corsale A.M.; Caccamo N.; Sireci G.; Dieli F.; Meraviglia S.; \u03b3\u03b4 T cells and tumor microenvironment: From immunosurveillance to tumor evasion. Front Immunol 2018,9,1395", "ArticleIdList": ["10.3389/fimmu.2018.01395", "29963061"]}, {"Citation": "Becker A.; Thakur B.K.; Weiss J.M.; Kim H.S.; Peinado H.; Lyden D.; Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis. Cancer Cell 2016,30(6),836-848", "ArticleIdList": ["10.1016/j.ccell.2016.10.009", "27960084"]}, {"Citation": "Kowal J.; Tkach M.; Th\u00e9ry C.; Biogenesis and secretion of exosomes. Curr Opin Cell Biol 2014,29,116-125", "ArticleIdList": ["10.1016/j.ceb.2014.05.004", "24959705"]}, {"Citation": "Mousavi S.; Moallem R.; Hassanian S.M.; Sadeghzade M.; Mardani R.; Ferns G.A.; Khazaei M.; Avan A.; Tumor-derived exosomes: Potential biomarkers and therapeutic target in the treatment of colorectal cancer. J Cell Physiol 2019,234(8),12422-12432", "ArticleIdList": ["10.1002/jcp.28080", "30637729"]}, {"Citation": "Cheng L.; Wu S.; Zhang K.; Qing Y.; Xu T.; A comprehensive overview of exosomes in ovarian cancer: Emerging biomarkers and therapeutic strategies. J Ovarian Res 2017,10(1),73", "ArticleIdList": ["10.1186/s13048-017-0368-6", "29100532"]}, {"Citation": "Gopikrishnan M.; R H.C.; R G.; Ashour H.M.; Pintus G.; Hammad M.; Kashyap M.K.; C G.P.D.; Zayed H.; Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer. Funct Integr Genomics 2023,23(2),184", "ArticleIdList": ["10.1007/s10142-023-01083-3", "37243750"]}, {"Citation": "Sharma J.; Balakrishnan L.; Kaushik S.; Kashyap M.K.; multi- omics approaches to study signaling pathways Frontiers Media SA 2020,829"}, {"Citation": "Hashemi Z.S.; Ghavami M.; Kashyap M.K.; Editorial: Exosomes, miRNAs, and lncRNAs in breast cancer: Therapeutic and diagnostic applications. Front Genet 2023,14,1192866", "ArticleIdList": ["10.3389/fgene.2023.1192866", "37229186"]}, {"Citation": "Conigliaro A.; Cicchini C.; Exosome-mediated signaling in epithelial to mesenchymal transition and tumor progression. J Clin Med 2018,8(1),26", "ArticleIdList": ["10.3390/jcm8010026", "30591649"]}, {"Citation": "Li K.; Chen Y.; Li A.; Tan C.; Liu X.; Exosomes play roles in sequential processes of tumor metastasis. Int J Cancer 2019,144(7),1486-1495", "ArticleIdList": ["10.1002/ijc.31774", "30155891"]}, {"Citation": "Nakamura K.; Sawada K.; Kinose Y.; Yoshimura A.; Toda A.; Nakatsuka E.; Hashimoto K.; Mabuchi S.; Morishige K.; Kurachi H.; Lengyel E.; Kimura T.; Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells. Mol Cancer Res 2017,15(1),78-92", "ArticleIdList": ["10.1158/1541-7786.MCR-16-0191", "27758876"]}, {"Citation": "Yoshimura A.; Sawada K.; Nakamura K.; Kinose Y.; Nakatsuka E.; Kobayashi M.; Miyamoto M.; Ishida K.; Matsumoto Y.; Kodama M.; Hashimoto K.; Mabuchi S.; Kimura T.; Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. BMC Cancer 2018,18(1),1065", "ArticleIdList": ["10.1186/s12885-018-4974-5", "30396333"]}, {"Citation": "Th\u00e9ry C.; Zitvogel L.; Amigorena S.; Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2002,2(8),569-579", "ArticleIdList": ["10.1038/nri855", "12154376"]}, {"Citation": "Ibrahim A.; Marb\u00e1n E.; Exosomes: Fundamental biology and roles in cardiovascular physiology. Annu Rev Physiol 2016,78(1),67-83", "ArticleIdList": ["10.1146/annurev-physiol-021115-104929", "26667071"]}, {"Citation": "Maia J.; Caja S.; Strano Moraes M.C.; Couto N.; Costa-Silva B.; Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol 2018,6(6),18", "ArticleIdList": ["10.3389/fcell.2018.00018", "29515996"]}, {"Citation": "Li N.; Zhao L.; Wei Y.; Ea V.L.; Nian H.; Wei R.; Recent advances of exosomes in immune-mediated eye diseases. Stem Cell Res Ther 2019,10(1),278", "ArticleIdList": ["10.1186/s13287-019-1372-0", "31470892"]}, {"Citation": "Kenny H.A.; Chiang C.Y.; White E.A.; Schryver E.M.; Habis M.; Romero I.L.; Ladanyi A.; Penicka C.V.; George J.; Matlin K.; Montag A.; Wroblewski K.; Yamada S.D.; Mazar A.P.; Bowtell D.; Lengyel E.; Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest 2014,124(10),4614-4628", "ArticleIdList": ["10.1172/JCI74778", "25202979"]}, {"Citation": "Mutsaers S.E.; The mesothelial cell. Int J Biochem Cell Biol 2004,36(1),9-16", "ArticleIdList": ["10.1016/S1357-2725(03)00242-5", "14592528"]}, {"Citation": "Peinado H.; Ale\u010dkovi\u0107 M.; Lavotshkin S.; Matei I.; Costa-Silva B.; Moreno-Bueno G.; Hergueta-Redondo M.; Williams C.; Garc\u00eda-Santos G.; Ghajar C.M.; Nitadori-Hoshino A.; Hoffman C.; Badal K.; Garcia B.A.; Callahan M.K.; Yuan J.; Martins V.R.; Skog J.; Kaplan R.N.; Brady M.S.; Wolchok J.D.; Chapman P.B.; Kang Y.; Bromberg J.; Lyden D.; Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012,18(6),883-891", "ArticleIdList": ["10.1038/nm.2753", "22635005"]}, {"Citation": "Yokoi A.; Yoshioka Y.; Yamamoto Y.; Ishikawa M.; Ikeda S.; Kato T.; Kiyono T.; Takeshita F.; Kajiyama H.; Kikkawa F.; Ochiya T.; Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun 2017,8(1),14470", "ArticleIdList": ["10.1038/ncomms14470", "28262727"]}, {"Citation": "Yi H.; Ye J.; Yang X-M.; Zhang L-W.; Zhang Z-G.; Chen Y-P.; High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis. Int J Clin Exp Pathol 2015,8(5),5062-5070", "ArticleIdList": ["26191200"]}, {"Citation": "Qiu J.J.; Lin X.J.; Tang X.Y.; Zheng T.T.; Lin Y.Y.; Hua K.Q.; Exosomal metastasis-associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int J Biol Sci 2018,14(14),1960-1973", "ArticleIdList": ["10.7150/ijbs.28048", "30585260"]}, {"Citation": "Czystowska-Kuzmicz M.; Sosnowska A.; Nowis D.; Ramji K.; Szajnik M.; Chlebowska-Tuz J.; Wolinska E.; Gaj P.; Grazul M.; Pilch Z.; Zerrouqi A.; Graczyk-Jarzynka A.; Soroczynska K.; Cierniak S.; Koktysz R.; Elishaev E.; Gruca S.; Stefanowicz A.; Blaszczyk R.; Borek B.; Gzik A.; Whiteside T.; Golab J.; Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun 2019,10(1),3000", "ArticleIdList": ["10.1038/s41467-019-10979-3", "31278254"]}, {"Citation": "Meng Y.; Kang S.; Fishman D.A.; Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells. Cancer Immunol Immunother 2005,54(8),807-814", "ArticleIdList": ["10.1007/s00262-004-0642-5", "15662527"]}, {"Citation": "Sawada K.; Mitra A.K.; Radjabi A.R.; Bhaskar V.; Kistner E.O.; Tretiakova M.; Jagadeeswaran S.; Montag A.; Becker A.; Kenny H.A.; Peter M.E.; Ramakrishnan V.; Yamada S.D.; Lengyel E.; Loss of E-cadherin promotes ovarian cancer metastasis via \u03b1 5-integrin, which is a therapeutic target. Cancer Res 2008,68(7),2329-2339", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5167", "18381440"]}, {"Citation": "Vella L.J.; The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol 2014,4,361", "ArticleIdList": ["10.3389/fonc.2014.00361", "25566500"]}, {"Citation": "Li W.; Zhang X.; Wang J.; Li M.; Cao C.; Tan J.; Ma D.; Gao Q.; TGF\u03b21 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells. Oncotarget 2017,8(56),96035-96047", "ArticleIdList": ["10.18632/oncotarget.21635", "29221185"]}, {"Citation": "Li P.; Kaslan M.; Lee S.H.; Yao J.; Gao Z.; Progress in exosome isolation techniques. Theranostics 2017,7(3),789-804", "ArticleIdList": ["10.7150/thno.18133", "28255367"]}, {"Citation": "Zhu L.; Sun H.T.; Wang S.; Huang S.L.; Zheng Y.; Wang C.Q.; Hu B.Y.; Qin W.; Zou T.T.; Fu Y.; Shen X.T.; Zhu W.W.; Geng Y.; Lu L.; Jia H.; Qin L.X.; Dong Q.Z.; Isolation and characterization of exosomes for cancer research. J Hematol Oncol 2020,13(1),152", "ArticleIdList": ["10.1186/s13045-020-00987-y", "33168028"]}, {"Citation": "Iwai K.; Minamisawa T.; Suga K.; Yajima Y.; Shiba K.; Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles 2016,5(1),30829", "ArticleIdList": ["10.3402/jev.v5.30829", "27193612"]}, {"Citation": "Helwa I.; Cai J.; Drewry M.D.; Zimmerman A.; Dinkins M.B.; Khaled M.L.; Seremwe M.; Dismuke W.M.; Bieberich E.; Stamer W.D.; Hamrick M.W.; Liu Y.; A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One 2017,12(1),e0170628", "ArticleIdList": ["10.1371/journal.pone.0170628", "28114422"]}, {"Citation": "Liang B.; Peng P.; Chen S.; Li L.; Zhang M.; Cao D.; Yang J.; Li H.; Gui T.; Li X.; Shen K.; Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics 2013,80,171-182", "ArticleIdList": ["10.1016/j.jprot.2012.12.029", "23333927"]}, {"Citation": "Dorayappan K.D.P.; Gardner M.L.; Hisey C.L.; Zingarelli R.A.; Smith B.Q.; Lightfoot M.D.S.; Gogna R.; Flannery M.M.; Hays J.; Hansford D.J.; Freitas M.A.; Yu L.; Cohn D.E.; Selvendiran K.; A microfluidic chip enables isolation of exosomes and establishment of their protein profiles and associated signaling pathways in ovarian cancer. Cancer Res 2019,79(13),3503-3513", "ArticleIdList": ["10.1158/0008-5472.CAN-18-3538", "31097475"]}, {"Citation": "Zhao Z.; Yang Y.; Zeng Y.; He M.; A microfluidic exosearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip 2016,16(3),489-496", "ArticleIdList": ["10.1039/C5LC01117E", "26645590"]}, {"Citation": "Ye D.; Gong M.; Deng Y.; Fang S.; Cao Y.; Xiang Y.; Shen Z.; Roles and clinical application of exosomal circRNAs in the diagnosis and treatment of malignant tumors. J Transl Med 2022,20(1),161", "ArticleIdList": ["10.1186/s12967-022-03367-x", "35382838"]}, {"Citation": "Hu C.; Jiang W.; Lv M.; Fan S.; Lu Y.; Wu Q.; Pi J.; Potentiality of exosomal proteins as novel cancer biomarkers for liquid biopsy. Front Immunol 2022,13,792046", "ArticleIdList": ["10.3389/fimmu.2022.792046", "35757760"]}, {"Citation": "Yang S.; Wang J.; Wang S.; Zhou A.; Zhao G.; Li P.; Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review). Int J Oncol 2022,61(2),91", "ArticleIdList": ["10.3892/ijo.2022.5381", "35674180"]}, {"Citation": "Zhang M.; He Y.; Sun X.; Li Q.; Wang W.; Zhao A.; Di W.; A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res 2014,7(1),19", "ArticleIdList": ["10.1186/1757-2215-7-19", "24507759"]}, {"Citation": "Li W.; Li C.; Zhou T.; Liu X.; Liu X.; Li X.; Chen D.; Role of exosomal proteins in cancer diagnosis. Mol Cancer 2017,16(1),145", "ArticleIdList": ["10.1186/s12943-017-0706-8", "28851367"]}, {"Citation": "Zhang B.; Chen F.; Xu Q.; Han L.; Xu J.; Gao L.; Sun X.; Li Y.; Li Y.; Qian M.; Sun Y.; Revisiting ovarian cancer microenvironment: A friend or a foe? Protein Cell 2018,9(8),674-692", "ArticleIdList": ["10.1007/s13238-017-0466-7", "28929459"]}, {"Citation": "Wang X.; Yao Y.; Jin M.; Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging (Albany NY) 2020,12(19),19095-19106", "ArticleIdList": ["10.18632/aging.103706", "33028742"]}, {"Citation": "Wu Y.; Yuan W.; Ding H.; Wu X.; Serum exosomal miRNA from endometriosis patients correlates with disease severity. Arch Gynecol Obstet 2022,305(1),117-127", "ArticleIdList": ["10.1007/s00404-021-06227-z", "34542679"]}, {"Citation": "Lin J; Li J; Huang B; Liu J; Chen X; Chen X-M; Exosomes: novel biomarkers for clinical diagnosis. The scientific world journal 2015,657086", "ArticleIdList": ["10.1155/2015/657086"]}, {"Citation": "Runz S.; Keller S.; Rupp C.; Stoeck A.; Issa Y.; Koensgen D.; Mustea A.; Sehouli J.; Kristiansen G.; Altevogt P.; Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 2007,107(3),563-571", "ArticleIdList": ["10.1016/j.ygyno.2007.08.064", "17900673"]}, {"Citation": "Jiang H.; Zhao H.; Zhang M.; He Y.; Li X.; Xu Y.; Liu X.; Hypoxia induced changes of exosome cargo and subsequent biological effects. Front Immunol 2022,13,824188", "ArticleIdList": ["10.3389/fimmu.2022.824188", "35444652"]}, {"Citation": "Kim Y.S.; Ahn J.S.; Kim S.; Kim H.J.; Kim S.H.; Kang J.S.; The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields. Korean J Physiol Pharmacol 2018,22(2),113-125", "ArticleIdList": ["10.4196/kjpp.2018.22.2.113", "29520164"]}, {"Citation": "Grass G.D.; Toole B.P.; How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep 2016,36(1),e00283", "ArticleIdList": ["10.1042/BSR20150256", "26604323"]}, {"Citation": "Shimizu A.; Sawada K.; Kimura T.; Pathophysiological role and potential therapeutic exploitation of exosomes in ovarian cancer. Cells 2020,9(4),814", "ArticleIdList": ["10.3390/cells9040814", "32230983"]}, {"Citation": "Nakamura K.; Sawada K.; Kobayashi M.; Miyamoto M.; Shimizu A.; Yamamoto M.; Kinose Y.; Kimura T.; Role of the exosome in ovarian cancer progression and its potential as a therapeutic target. Cancers (Basel) 2019,11(8),1147", "ArticleIdList": ["10.3390/cancers11081147", "31405096"]}, {"Citation": "Tang M.K.S.; Wong A.S.T.; Exosomes: Emerging biomarkers and targets for ovarian cancer. Cancer Lett 2015,367(1),26-33", "ArticleIdList": ["10.1016/j.canlet.2015.07.014", "26189430"]}, {"Citation": "Datta A.; Kim H.; McGee L.; Johnson A.E.; Talwar S.; Marugan J.; Southall N.; Hu X.; Lal M.; Mondal D.; Ferrer M.; Abdel-Mageed A.B.; High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer. Sci Rep 2018,8(1),8161", "ArticleIdList": ["10.1038/s41598-018-26411-7", "29802284"]}, {"Citation": "Doyle L.; Wang M.; Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 2019,8(7),727", "ArticleIdList": ["10.3390/cells8070727", "31311206"]}, {"Citation": "Zhang Y.; Li J.; Gao W.; Xie N.; Exosomes as anticancer drug delivery vehicles: prospects and challenges. Frontiers in Bioscience-Landmark 2022,27(10),293", "ArticleIdList": ["10.31083/j.fbl2710293", "36336863"]}, {"Citation": "Raguraman R.; Bhavsar D.; Kim D.; Ren X.; Sikavitsas V.; Munshi A.; Ramesh R.; Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett 2023,558,216093", "ArticleIdList": ["10.1016/j.canlet.2023.216093", "36822543"]}, {"Citation": "Herrmann I.K.; Wood M.J.A.; Fuhrmann G.; Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 2021,16(7),748-759", "ArticleIdList": ["10.1038/s41565-021-00931-2", "34211166"]}, {"Citation": "Melzer C.; Rehn V.; Yang Y.; B\u00e4hre H.; von der Ohe J.; Hass R.; Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers (Basel) 2019,11(6),798", "ArticleIdList": ["10.3390/cancers11060798", "31181850"]}, {"Citation": "Brown A.; Kumar S.; Tchounwou P.B.; Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther 2019,11(4),97", "ArticleIdList": ["32148661"]}, {"Citation": "Shtam T.A.; Kovalev R.A.; Varfolomeeva E.Y.; Makarov E.M.; Kil Y.V.; Filatov M.V.; Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 2013,11(1),88", "ArticleIdList": ["10.1186/1478-811X-11-88", "24245560"]}, {"Citation": "Liang X.; Ye X.; Wang C.; Xing C.; Miao Q.; Xie Z.; Chen X.; Zhang X.; Zhang H.; Mei L.; Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release 2019,296,150-161", "ArticleIdList": ["10.1016/j.jconrel.2019.01.027", "30682441"]}, {"Citation": "Zheng Z.; Li Z.; Xu C.; Guo B.; Guo P.; Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping. J Control Release 2019,311-312,43-49", "ArticleIdList": ["10.1016/j.jconrel.2019.08.021", "31446085"]}, {"Citation": "Zeh N.; Schneider H.; Mathias S.; Raab N.; Kleemann M.; Schmidt-Hertel S.; Weis B.; Wissing S.; Strempel N.; Handrick R.; Otte K.; Human CAP cells represent a novel source for functional, miRNA-loaded exosome production. PLoS One 2019,14(8),e0221679", "ArticleIdList": ["10.1371/journal.pone.0221679", "31461486"]}, {"Citation": "Hu Y.; Li D.; Wu A.; Qiu X.; Di W.; Huang L.; Qiu L.; TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Cancer Lett 2017,393,60-67", "ArticleIdList": ["10.1016/j.canlet.2017.02.009", "28216373"]}, {"Citation": "Wei L.; He Y.; Bi S.; Li X.; Zhang J.; Zhang S.; miRNA-199b-3p suppresses growth and progression of ovarian cancer via the CHK1/E-cadherin/EMT signaling pathway by targeting ZEB1. Oncol Rep 2020,45(2),569-581", "ArticleIdList": ["10.3892/or.2020.7895", "33416170"]}, {"Citation": "Hussain M.W.A.; Jahangir S.; Ghosh B.; Yesmin F.; Anis A.; Satil S.N.; Anwar F.; Rashid M.H.; Exosomes for regulation of immune responses and immunotherapy. Journal of Nanotheranostics 2022,3(1),55-85", "ArticleIdList": ["10.3390/jnt3010005"]}, {"Citation": "Bhatnagar S.; Schorey J.S.; Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem 2007,282(35),25779-25789", "ArticleIdList": ["10.1074/jbc.M702277200", "17591775"]}, {"Citation": "Vega V.L.; Rodr\u00edguez-Silva M.; Frey T.; Gehrmann M.; Diaz J.C.; Steinem C.; Multhoff G.; Arispe N.; De Maio A.; Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol 2008,180(6),4299-4307", "ArticleIdList": ["10.4049/jimmunol.180.6.4299", "18322243"]}, {"Citation": "Gastpar R.; Gehrmann M.; Bausero M.A.; Asea A.; Gross C.; Schroeder J.A.; Multhoff G.; Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005,65(12),5238-5247", "ArticleIdList": ["10.1158/0008-5472.CAN-04-3804", "15958569"]}, {"Citation": "Skokos D.; Botros H.G.; Demeure C.; Morin J.; Peronet R.; Birkenmeier G.; Boudaly S.; M\u00e9cheri S.; Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003,170(6),3037-3045", "ArticleIdList": ["10.4049/jimmunol.170.6.3037", "12626558"]}, {"Citation": "Segura E.; Amigorena S.; Th\u00e9ry C.; Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 2005,35(2),89-93", "ArticleIdList": ["10.1016/j.bcmd.2005.05.003", "15990342"]}, {"Citation": "Abusamra A.J.; Zhong Z.; Zheng X.; Li M.; Ichim T.E.; Chin J.L.; Min W.P.; Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 2005,35(2),169-173", "ArticleIdList": ["10.1016/j.bcmd.2005.07.001", "16081306"]}, {"Citation": "Theodoraki M.N.; Yerneni S.S.; Hoffmann T.K.; Gooding W.E.; Whiteside T.L.; Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients. Clin Cancer Res 2018,24(4),896-905", "ArticleIdList": ["10.1158/1078-0432.CCR-17-2664", "29233903"]}, {"Citation": "Chen G.; Huang A.C.; Zhang W.; Zhang G.; Wu M.; Xu W.; Yu Z.; Yang J.; Wang B.; Sun H.; Xia H.; Man Q.; Zhong W.; Antelo L.F.; Wu B.; Xiong X.; Liu X.; Guan L.; Li T.; Liu S.; Yang R.; Lu Y.; Dong L.; McGettigan S.; Somasundaram R.; Radhakrishnan R.; Mills G.; Lu Y.; Kim J.; Chen Y.H.; Dong H.; Zhao Y.; Karakousis G.C.; Mitchell T.C.; Schuchter L.M.; Herlyn M.; Wherry E.J.; Xu X.; Guo W.; Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 2018,560(7718),382-386", "ArticleIdList": ["10.1038/s41586-018-0392-8", "30089911"]}, {"Citation": "Chen J.; Song Y.; Miao F.; Chen G.; Zhu Y.; Wu N.; Pang L.; Chen Z.; Chen X.; PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8 T cell exhaustion during metastasis. Cancer Sci 2021,112(9),3437-3454", "ArticleIdList": ["10.1111/cas.15033", "34152672"]}, {"Citation": "Taylor D.D.; Ger\u00e7el-Taylor C.; Lyons K.S.; Stanson J.; Whiteside T.L.; T-cell apoptosis and suppression of T-cell receptor/CD3-\u03b6 by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 2003,9(14),5113-5119", "ArticleIdList": ["14613988"]}, {"Citation": "Klinker M.W.; Lizzio V.; Reed T.J.; Fox D.A.; Lundy S.K.; Human B cell-derived lymphoblastoid cell lines constitutively produce Fas ligand and secrete MHCII+ FasL+ killer exosomes. Front Immunol 2014,5,144", "ArticleIdList": ["10.3389/fimmu.2014.00144", "24765093"]}, {"Citation": "Clayton A.; Mitchell J.P.; Court J.; Linnane S.; Mason M.D.; Tabi Z.; Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 2008,180(11),7249-7258", "ArticleIdList": ["10.4049/jimmunol.180.11.7249", "18490724"]}, {"Citation": "Vulpis E.; Cecere F.; Molfetta R.; Soriani A.; Fionda C.; Peruzzi G.; Caracciolo G.; Palchetti S.; Masuelli L.; Simonelli L.; D\u2019Oro U.; Abruzzese M.P.; Petrucci M.T.; Ricciardi M.R.; Paolini R.; Cippitelli M.; Santoni A.; Zingoni A.; Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis. OncoImmunology 2017,6(3),e1279372", "ArticleIdList": ["10.1080/2162402X.2017.1279372", "28405503"]}, {"Citation": "Bald T.; Krummel M.F.; Smyth M.J.; Barry K.C.; The NK cell-cancer cycle: Advances and new challenges in NK cell\u2013based immunotherapies. Nat Immunol 2020,21(8),835-847", "ArticleIdList": ["10.1038/s41590-020-0728-z", "32690952"]}, {"Citation": "Elsner L.; Muppala V.; Gehrmann M.; Lozano J.; Malzahn D.; Bickeb\u00f6ller H.; Brunner E.; Zientkowska M.; Herrmann T.; Walter L.; Alves F.; Multhoff G.; Dressel R.; The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands. J Immunol 2007,179(8),5523-5533", "ArticleIdList": ["10.4049/jimmunol.179.8.5523", "17911639"]}, {"Citation": "Liu C.; Yu S.; Zinn K.; Wang J.; Zhang L.; Jia Y.; Kappes J.C.; Barnes S.; Kimberly R.P.; Grizzle W.E.; Zhang H.G.; Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006,176(3),1375-1385", "ArticleIdList": ["10.4049/jimmunol.176.3.1375", "16424164"]}, {"Citation": "Ashiru O.; Boutet P.; Fern\u00e1ndez-Messina L.; Ag\u00fcera-Gonz\u00e1lez S.; Skepper J.N.; Val\u00e9s-G\u00f3mez M.; Reyburn H.T.; Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res 2010,70(2),481-489", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1688", "20068167"]}, {"Citation": "Pritchard A.; Tousif S.; Wang Y.; Hough K.; Khan S.; Strenkowski J.; Chacko B.K.; Darley-Usmar V.M.; Deshane J.S.; Lung tumor cell-derived exosomes promote M2 macrophage polarization. Cells 2020,9(5),1303", "ArticleIdList": ["10.3390/cells9051303", "32456301"]}, {"Citation": "Jiang H.; Zhou L.; Shen N.; Ning X.; Wu D.; Jiang K.; Huang X.; M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-\u03baB pathway. Cell Death Dis 2022,13(2),183", "ArticleIdList": ["10.1038/s41419-022-04640-z", "35210436"]}, {"Citation": "Khare D.; Or R.; Resnick I.; Barkatz C.; Almogi-Hazan O.; Avni B.; Mesenchymal stromal cell-derived exosomes affect mRNA expression and function of B-lymphocytes. Front Immunol 2018,9,3053", "ArticleIdList": ["10.3389/fimmu.2018.03053", "30622539"]}, {"Citation": "Ye L.; Zhang Q.; Cheng Y.; Chen X.; Wang G.; Shi M.; Zhang T.; Cao Y.; Pan H.; Zhang L.; Wang G.; Deng Y.; Yang Y.; Chen G.; Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 regulatory B cell expansion. J Immunother Cancer 2018,6(1),145", "ArticleIdList": ["10.1186/s40425-018-0451-6", "30526680"]}, {"Citation": "Yu S.; Liu C.; Su K.; Wang J.; Liu Y.; Zhang L.; Li C.; Cong Y.; Kimberly R.; Grizzle W.E.; Falkson C.; Zhang H.G.; Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007,178(11),6867-6875", "ArticleIdList": ["10.4049/jimmunol.178.11.6867", "17513735"]}, {"Citation": "Hinata M.; Kunita A.; Abe H.; Morishita Y.; Sakuma K.; Yamashita H.; Seto Y.; Ushiku T.; Fukayama M.; Exosomes of Epstein-Barr virus-associated gastric carcinoma suppress dendritic cell maturation. Microorganisms 2020,8(11),1776", "ArticleIdList": ["10.3390/microorganisms8111776", "33198173"]}, {"Citation": "Ren W.; Zhang X.; Li W.; Feng Q.; Feng H.; Tong Y.; Rong H.; Wang W.; Zhang D.; Zhang Z.; Tu S.; Zhu X.; Zhang Q.; Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer. Cancer Manag Res 2019,11,4023-4040", "ArticleIdList": ["10.2147/CMAR.S198886", "31190980"]}, {"Citation": "Guo X.; Qiu W.; Liu Q.; Qian M.; Wang S.; Zhang Z.; Gao X.; Chen Z.; Xue H.; Li G.; Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways. Oncogene 2018,37(31),4239-4259", "ArticleIdList": ["10.1038/s41388-018-0261-9", "29713056"]}, {"Citation": "Gong X.; Chi H.; Strohmer D.F.; Teichmann A.T.; Xia Z.; Wang Q.; Exosomes: A potential tool for immunotherapy of ovarian cancer. Front Immunol 2023,13,1089410", "ArticleIdList": ["10.3389/fimmu.2022.1089410", "36741380"]}, {"Citation": "Zhang M.; Hu S.; Liu L.; Dang P.; Liu Y.; Sun Z.; Qiao B.; Wang C.; Engineered exosomes from different sources for cancer- targeted therapy. Signal Transduct Target Ther 2023,8(1),124", "ArticleIdList": ["10.1038/s41392-023-01382-y", "36922504"]}, {"Citation": "Peterson M.F.; Otoc N.; Sethi J.K.; Gupta A.; Antes T.J.; Integrated systems for exosome investigation. Methods 2015,87,31-45", "ArticleIdList": ["10.1016/j.ymeth.2015.04.015", "25916618"]}, {"Citation": "Davies R.T.; Kim J.; Jang S.C.; Choi E.J.; Gho Y.S.; Park J.; Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip 2012,12(24),5202-5210", "ArticleIdList": ["10.1039/c2lc41006k", "23111789"]}, {"Citation": "Huang X.; Wu W.; Jing D.; Yang L.; Guo H.; Wang L.; Zhang W.; Pu F.; Shao Z.; Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy. J Control Release 2022,343,107-117", "ArticleIdList": ["10.1016/j.jconrel.2022.01.026", "35077741"]}, {"Citation": "Wang J.; Wang C.; Li Y.; Li M.; Zhu T.; Shen Z.; Wang H.; Lv W.; Wang X.; Cheng X.; Xie X.; Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer. Clin Transl Med 2021,11(5),e425", "ArticleIdList": ["10.1002/ctm2.425", "34047469"]}, {"Citation": "Wan Y.; Wang L.; Zhu C.; Zheng Q.; Wang G.; Tong J.; Fang Y.; Xia Y.; Cheng G.; He X.; Zheng S.Y.; Aptamer-conjugated extracellular nanovesicles for targeted drug delivery. Cancer Res 2018,78(3),798-808", "ArticleIdList": ["10.1158/0008-5472.CAN-17-2880", "29217761"]}, {"Citation": "Yi K.; Rong Y.; Huang L.; Tang X.; Zhang Q.; Wang W.; Wu J.; Wang F.; Aptamer\u2013exosomes for tumor theranostics. ACS Sens 2021,6(4),1418-1429", "ArticleIdList": ["10.1021/acssensors.0c02237", "33755415"]}, {"Citation": "Zhang J.; Ji C.; Zhang H.; Shi H.; Mao F.; Qian H.; Xu W.; Wang D.; Pan J.; Fang X.; Santos H.A.; Zhang X.; Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci Adv 2022,8(2),eabj8207", "ArticleIdList": ["10.1126/sciadv.abj8207", "35020437"]}, {"Citation": "Cheng L.; Zhang X.; Tang J.; Lv Q.; Liu J.; Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy. Biomaterials 2021,275,120964", "ArticleIdList": ["10.1016/j.biomaterials.2021.120964", "34147721"]}, {"Citation": "Guo Y.; Wan Z.; Zhao P.; Wei M.; Liu Y.; Bu T.; Sun W.; Li Z.; Yuan L.; Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes. J Nanobiotechnology 2021,19(1),402", "ArticleIdList": ["10.1186/s12951-021-01145-3", "34863187"]}, {"Citation": "Feng L.; Dong Z.; Tao D.; Zhang Y.; Liu Z.; The acidic tumor microenvironment: A target for smart cancer nano-theranostics. Natl Sci Rev 2018,5(2),269-286", "ArticleIdList": ["10.1093/nsr/nwx062"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "12"}, {"Year": "2023", "Month": "10", "Day": "22"}, {"Year": "2023", "Month": "10", "Day": "25"}, {"Year": "2024", "Month": "8", "Day": "6", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "29", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "29", "Hour": "8", "Minute": "46"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38284712", "10.2174/0115680096281906231213055422", "CCDT-EPUB-137952"]}}]}